These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 31467400)
1. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells. Mattern J; Roghi CS; Hurtz M; Knäuper V; Edwards DR; Poghosyan Z Sci Rep; 2019 Aug; 9(1):12540. PubMed ID: 31467400 [TBL] [Abstract][Full Text] [Related]
2. Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer. Maretzky T; Le Gall SM; Worpenberg-Pietruk S; Eder J; Overall CM; Huang XY; Poghosyan Z; Edwards DR; Blobel CP Cancer Res; 2009 Jun; 69(11):4573-6. PubMed ID: 19487280 [TBL] [Abstract][Full Text] [Related]
3. The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. Najy AJ; Day KC; Day ML J Biol Chem; 2008 Jun; 283(26):18393-401. PubMed ID: 18434311 [TBL] [Abstract][Full Text] [Related]
4. ADAM15 to α5β1 integrin switch in colon carcinoma cells: a late event in cancer progression associated with tumor dedifferentiation and poor prognosis. Toquet C; Colson A; Jarry A; Bezieau S; Volteau C; Boisseau P; Merlin D; Laboisse CL; Mosnier JF Int J Cancer; 2012 Jan; 130(2):278-87. PubMed ID: 21190186 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays. Maretzky T; Yang G; Ouerfelli O; Overall CM; Worpenberg S; Hassiepen U; Eder J; Blobel CP Biochem J; 2009 Apr; 420(1):105-13. PubMed ID: 19207106 [TBL] [Abstract][Full Text] [Related]
6. ADAM15 regulates endothelial permeability and neutrophil migration via Src/ERK1/2 signalling. Sun C; Wu MH; Guo M; Day ML; Lee ES; Yuan SY Cardiovasc Res; 2010 Jul; 87(2):348-55. PubMed ID: 20189953 [TBL] [Abstract][Full Text] [Related]
7. The role of the disintegrin metalloproteinase ADAM15 in prostate cancer progression. Lucas N; Day ML J Cell Biochem; 2009 Apr; 106(6):967-74. PubMed ID: 19229865 [TBL] [Abstract][Full Text] [Related]
8. ADAM15 is an adherens junction molecule whose surface expression can be driven by VE-cadherin. Ham C; Levkau B; Raines EW; Herren B Exp Cell Res; 2002 Oct; 279(2):239-47. PubMed ID: 12243749 [TBL] [Abstract][Full Text] [Related]
9. Deletion of sorting nexin 27 suppresses proliferation in highly aggressive breast cancer MDA-MB-231 cells in vitro and in vivo. Zhang J; Li K; Zhang Y; Lu R; Wu S; Tang J; Xia Y; Sun J BMC Cancer; 2019 Jun; 19(1):555. PubMed ID: 31182056 [TBL] [Abstract][Full Text] [Related]
10. Claudin 1 Expression Levels Affect miRNA Dynamics in Human Basal-Like Breast Cancer Cells. Majer A; Blanchard AA; Medina S; Booth SA; Myal Y DNA Cell Biol; 2016 Jul; 35(7):328-39. PubMed ID: 26982264 [TBL] [Abstract][Full Text] [Related]
11. ADAM15 is involved in MICB shedding and mediates the effects of gemcitabine on MICB shedding in PANC-1 pancreatic cancer cells. Duan X; Mao X; Sun W Mol Med Rep; 2013 Mar; 7(3):991-7. PubMed ID: 23314034 [TBL] [Abstract][Full Text] [Related]
12. Alternative splicing of ADAM15 regulates its interactions with cellular SH3 proteins. Kleino I; Ortiz RM; Yritys M; Huovila AP; Saksela K J Cell Biochem; 2009 Nov; 108(4):877-85. PubMed ID: 19718658 [TBL] [Abstract][Full Text] [Related]
13. A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation. Yang X; Meegan JE; Jannaway M; Coleman DC; Yuan SY Cardiovasc Res; 2018 Nov; 114(13):1752-1763. PubMed ID: 29939250 [TBL] [Abstract][Full Text] [Related]
14. ADAM15 gene structure and differential alternative exon use in human tissues. Kleino I; Ortiz RM; Huovila AP BMC Mol Biol; 2007 Oct; 8():90. PubMed ID: 17937806 [TBL] [Abstract][Full Text] [Related]
15. ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer. Lorenzatti Hiles G; Bucheit A; Rubin JR; Hayward A; Cates AL; Day KC; El-Sawy L; Kunju LP; Daignault S; Lee CT; Liebert M; Hussain M; Day ML PLoS One; 2016; 11(3):e0150138. PubMed ID: 26930657 [TBL] [Abstract][Full Text] [Related]
16. ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells. Micocci KC; Moritz MN; Lino RL; Fernandes LR; Lima AG; Figueiredo CC; Morandi V; Selistre-de-Araujo HS Biochimie; 2016; 128-129():174-82. PubMed ID: 27554339 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-147b regulates vascular endothelial barrier function by targeting ADAM15 expression. Chatterjee V; Beard RS; Reynolds JJ; Haines R; Guo M; Rubin M; Guido J; Wu MH; Yuan SY PLoS One; 2014; 9(10):e110286. PubMed ID: 25333931 [TBL] [Abstract][Full Text] [Related]
18. Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma. Zhong JL; Poghosyan Z; Pennington CJ; Scott X; Handsley MM; Warn A; Gavrilovic J; Honert K; Krüger A; Span PN; Sweep FC; Edwards DR Mol Cancer Res; 2008 Mar; 6(3):383-94. PubMed ID: 18296648 [TBL] [Abstract][Full Text] [Related]
19. ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation. Chen Q; Meng LH; Zhu CH; Lin LP; Lu H; Ding J Int J Biochem Cell Biol; 2008; 40(10):2164-73. PubMed ID: 18387333 [TBL] [Abstract][Full Text] [Related]
20. ERalpha signaling through slug regulates E-cadherin and EMT. Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]